Tolerability, Safety, and Activity of SRX246 in Irritable Subjects With Huntington's Disease (Q65340124)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Tolerability, Safety, and Activity of SRX246 in Irritable Subjects With Huntington's Disease |
clinical trial |
Statements
An Exploratory Phase II Study to Determine the Tolerability, Safety, and Activity of a Novel Vasopressin 1a Receptor Antagonist (SRX246) in Irritable Subjects With Huntington's Disease (HD) (English)
0 references
10 May 2016
0 references
10 September 2018
0 references
106
0 references
18 year
0 references